X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse SUVEN LIFE with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE   TEVA PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
TEVA PHARMA
Dec-13
SUVEN LIFE/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3392,675-   
Low Rs1442,324-   
Sales per share (Unadj.) Rs39.21,535.0-  
Earnings per share (Unadj.) Rs7.595.9-  
Cash flow per share (Unadj.) Rs8.8220.0-  
Dividends per share (Unadj.) Rs2.0083.94-  
Dividend yield (eoy) %0.83.4 24.7%  
Book value per share (Unadj.) Rs49.01,705.1-  
Shares outstanding (eoy) m127.28848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.21.6 377.9%   
Avg P/E ratio x32.426.1 124.2%  
P/CF ratio (eoy) x27.511.4 242.2%  
Price / Book Value ratio x4.91.5 336.2%  
Dividend payout %26.887.5 30.6%   
Avg Mkt Cap Rs m30,7322,119,254 1.5%   
No. of employees `0001.044.9 2.1%   
Total wages/salary Rs m4160-   
Avg. sales/employee Rs Th5,236.128,962.5 18.1%   
Avg. wages/employee Rs Th436.50-   
Avg. net profit/employee Rs Th995.51,809.3 55.0%   
INCOME DATA
Net Sales Rs m4,9951,301,721 0.4%  
Other income Rs m1940-   
Total revenues Rs m5,1891,301,721 0.4%   
Gross profit Rs m1,233356,477 0.3%  
Depreciation Rs m167105,219 0.2%   
Interest Rs m5425,568 0.2%   
Profit before tax Rs m1,205225,690 0.5%   
Minority Interest Rs m01,025 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-148,153 0.0%   
Tax Rs m255-2,755 -9.3%   
Profit after tax Rs m95081,318 1.2%  
Gross profit margin %24.727.4 90.1%  
Effective tax rate %21.2-1.2 -1,733.7%   
Net profit margin %19.06.2 304.3%  
BALANCE SHEET DATA
Current assets Rs m4,986879,178 0.6%   
Current liabilities Rs m1,042766,717 0.1%   
Net working cap to sales %79.08.6 913.9%  
Current ratio x4.81.1 417.2%  
Inventory Days Days6191 67.2%  
Debtors Days Days3996 40.8%  
Net fixed assets Rs m3,126425,171 0.7%   
Share capital Rs m1273,204 4.0%   
"Free" reserves Rs m3,7170-   
Net worth Rs m6,2361,445,965 0.4%   
Long term debt Rs m432665,599 0.1%   
Total assets Rs m8,0792,974,850 0.3%  
Interest coverage x23.29.8 236.4%   
Debt to equity ratio x0.10.5 15.1%  
Sales to assets ratio x0.60.4 141.3%   
Return on assets %12.43.6 345.8%  
Return on equity %15.25.6 270.8%  
Return on capital %18.94.9 382.8%  
Exports to sales %87.50-   
Imports to sales %12.20-   
Net fx Rs m3,7240-   
CASH FLOW
From Operations Rs m922207,427 0.4%  
From Investments Rs m-619-73,500 0.8%  
From Financial Activity Rs m-698-248,823 0.3%  
Net Cashflow Rs m-396-114,895 0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.08 Rs / USD

Compare SUVEN LIFE With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare SUVEN LIFE With: ALKEM LABORATORIES  TORRENT PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  CADILA HEALTHCARE  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 22, 2017 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - STERLING BIOTECH COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS